PSYCHÉDÉLIQUES ADDICTION TREATMENT

Psilocybin-containing mushrooms have been used for centuries in spiritual and ceremonial contexts. Today, they are being investigated for therapeutic potential in treating depression, anxiety, and addiction. However, frequent or heavy recreational use carries risks: HPPD, triggering of latent mental health conditions, and significant psychological dependence. Users who self-medicate underlying trauma or mental health issues with psilocybin often find that the temporary relief is followed by worsened symptoms. Commercial mushroom products and grow kits have made high-potency strains widely available, increasing these risks.

Ketamine is a dissociative anaesthetic that produces feelings of detachment from the body and environment. While ketamine-assisted therapy is emerging as a promising treatment for depression, recreational use carries serious risks. Frequent use can cause severe bladder damage (ketamine cystitis), requiring surgical intervention; cognitive impairment, particularly in memory and executive function; and the development of tolerance that drives escalation to dangerous doses. K-hole experiences — profound dissociation — can be psychologically traumatic. Dependence is primarily psychological but can be intense.

MDMA occupies a unique position among psychedelics, combining stimulant and empathogenic effects. It produces feelings of emotional openness, tactile enhancement, and profound connection with others — effects that have led to its exploration in couples therapy and PTSD treatment. However, recreational use carries significant neurochemical risks. MDMA depletes serotonin reserves, and frequent use can cause long-term serotonin system dysfunction, leading to persistent depression, anxiety, and memory impairment. The drug is also commonly adulterated, particularly with PMA/PMMA which has a much narrower safety margin.

DMT is a powerful, short-acting hallucinogen that produces intense psychedelic experiences lasting 15-30 minutes when smoked or vaporised. Users often report contact with seemingly autonomous entities and journeys to other « realms. » While physical dependence is absent, the intensity and perceived significance of DMT experiences can lead to psychological fixation. The primary risks include psychological distress from overwhelming experiences, triggering of latent psychosis in vulnerable individuals, and the physical risks of using DMT in unsafe settings due to the complete dissociation from the environment during the experience.

Le LSD est l’un des hallucinogènes les plus puissants. Il n’y a pas de dépendance physique, mais une dépendance psychologique peut se développer, ainsi que le déclenchement de troubles mentaux sous-jacents.

Les champignons à psilocybine sont étudiés pour leur potentiel thérapeutique. L’usage récréatif fréquent comporte des risques de HPPD et de déclenchement de troubles mentaux.

La kétamine est un anesthésique dissociatif. L’usage fréquent peut provoquer des lésions vésicales graves et un déclin cognitif.

Le MDMA combine des effets stimulants et empathogènes. Il épuise les réserves de sérotonine et peut causer une dépression persistante.

Le DMT est un hallucinogène puissant à action courte (15-30 minutes). Les risques incluent la détresse psychologique et le déclenchement d’une psychose latente.